StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics cash

Cash and short-term investments held at the end of each period.

Medicenna Therapeutics's cash was C$33.60M at Mar 31, 2023. For fiscal 2023 it was C$33.60M, up 63.6% from the year before. The highest annual figure on record is C$33.60M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2023Mar 31, 2023C$33.60M+63.6%
FY2022Mar 31, 2022C$20.54M-32.4%
FY2021Mar 31, 2021C$30.38M+33.8%
FY2020Mar 31, 2020C$22.70M+857.3%
FY2019Mar 31, 2019C$2.37M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ1 2023Mar 31, 2023C$33.60M+10.6%
Q3 FY2023CQ4 2022Dec 31, 2022C$20.54M-9.5%
Q4 FY2022CQ1 2022Mar 31, 2022C$20.54M-9.5%
Q3 FY2022CQ4 2021Dec 31, 2021C$30.38M+1181.1%
Q4 FY2021CQ1 2021Mar 31, 2021C$30.38M–
Q3 FY2021CQ4 2020Dec 31, 2020C$22.70M–
Q4 FY2020CQ1 2020Mar 31, 2020C$22.70M–
Q4 FY2019CQ1 2019Mar 31, 2019C$2.37M–

More Medicenna Therapeutics figures

See a number that looks wrong?